Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy

0
228

Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Low Risk Stocks for a Retirement Stock Portfolio.

Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy

Janux Therapeutics said on January 22 that it has partnered with Bristol-Myers Squibb Company (NYSE:BMY) to develop a new cancer treatment, according to Reuters. The announcement was well received by the market, with Janux shares jumping more than 12% in premarket trading. The therapy is aimed at solid tumors, cancers that grow as masses in organs like the lung, breast, colon, or pancreas. Janux said the drug is designed to target a tumor marker that shows up across several cancer types, which could give it wider use if development is successful.

Chief executive David Campbell described the agreement as a major step forward for the company. He said the collaboration combines…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here